India Active Pharmaceutical Ingredients Market Is Estimated To Witness High Growth Owing To Increased Genericization And Patent Expiry Trends

Poonam

India Active Pharmaceutical Ingredients Market Is Estimated To Witness High Growth Owing To Increased Genericization And Patent Expiry Trends

The India Active Pharmaceutical Ingredients Market is estimated to be valued at US$ 23,449.8 Mn in 2023 and is expected to exhibit a CAGR of 8.3% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Active pharmaceutical ingredients (API) are the components of any drug that produce its effect. APIs are used in the production of pharmaceutical drug products and are the active components of formulations that treat the various conditions. APIs provide advantages such as cost-effectiveness, higher productivity, and greater control over manufacturing procedures. Increasing prevalence of chronic diseases and rising demand for generic drugs are fueling the need for APIs in India.

Market key trends:

One of the major trends driving the India active pharmaceutical ingredients market is increased genericization and patent expiries. As patents for many blockbuster drugs expire in the coming years, it provides an opportunity for generic drug makers to manufacture low-cost versions of those drugs. This has been a major factor for the growth of the API industry in India. As India has emerged as the largest provider of generic drugs globally, accounting for 20% of world's export volume of generic medicines, the demand for APIs is projected to rise substantially over the forecast period.

Porter’s Analysis

Threat of new entrants: The significant investment required to setup manufacturing facilities and obtain regulatory approvals pose barriers for new entrants.

Bargaining power of buyers: Large pharmaceutical companies have significant bargaining power over API suppliers due to their large scale operations and ability to source from alternative suppliers globally.

Bargaining power of suppliers: The presence of well established API players limits the bargaining power of suppliers in the market. However, specialized APIs have fewer alternatives.

Threat of new substitutes: APIs have limited threat from substitutes as they provide the core ingredients for drug formulations with no close alternatives.

Competitive rivalry: High as API manufacturers compete based on innovation, quality, and pricing.

SWOT Analysis

Strengths: India has a large pool of pharmaceutical talents and regulatory policies supporting the growth of pharmaceutical industries.

Weaknesses: Heavy dependence on imports for certain raw materials and key starting materials increases production costs. High working capital requirements and pricing pressures impact margins.

Opportunities: Growing generics market, increasing exports, and focus on specialized APIs present profitable opportunities.

Threats: Stringent regulatory norms and environmental policies increases compliance burden. Entry of Chinese players impacts pricing and market share.

Key Takeaways

The global India Active Pharmaceutical Ingredients Market Share is expected to witness high growth, exhibiting CAGR of 8.3% over the forecast period, due to increasing demand for generic drugs. Growing geriatric population, rising healthcare expenditure, and patents expiries of blockbuster drugs drive generic drugs demand.

Regional analysis: Southern and Western regions dominate India's API market, accounting for over 60% share collectively. Rising pharmaceutical manufacturing in Kerala, Karnataka, Gujarat, and Maharashtra aid regional market growth. Northern states growth hampered by lack of infrastructure but witnessing initiatives like Pharma City to bolster manufacturing.

Key players operating in the India Active Pharmaceutical Ingredients market are Teva Pharmaceutical Industries Ltd., Solara, Aurobindo Pharma Limited, Dr. Reddy's Laboratories, Lupin Limited, Sun Pharmaceutical Industries Limited, Divis Laboratories Ltd., Aarti Drugs Ltd., Hikal Ltd., Neuland Labs, Century Pharmaceuticals Ltd., Proventus Life Sciences Pvt Ltd, Chiral Drugs Pvt Ltd, USV Private Limited, and ASolution Pharmaceuticals Pvt. Ltd. All major players focus on product development and expansion to strengthen market position.

For more insights, read- https://www.pressreleasebulletin.com/india-active-pharmaceutical-ingredients-market-trends-size-and-share-analysis/

Poonam

India Active Pharmaceutical Ingredients Market Is Estimated To Witness High Growth Owing To Increasing Generic Drug Production And Rising Demand For APIs in Drug Development

Ben Wood 2023-10-20

The market is driven by the increasing production of generic drugs and the rising demand for APIs in drug development. With a favorable regulatory environment and a robust healthcare infrastructure, the Indian API market is poised for rapid growth. SWOT Analysis: Strength: India's active pharmaceutical ingredients (API) market has a strong domestic manufacturing base, with a wide range of API production capabilities. Opportunity: The India API market has significant growth opportunities due to the rising demand for generic drugs globally. Threats: The India API market could face threats from increasing competition from other low-cost manufacturing countries, such as China.

The Active Pharmaceutical Ingredients Market Is Estimated To Witness High Growth Owing To Opportunity In Generics Drugs Manufacturer

Poonam 2024-01-05

The global Active Pharmaceutical Ingredients Market is estimated to be valued at US$ 7. Porter's Analysis Threat of new entrants: The Active Pharmaceutical Ingredients market has moderate barriers to entry due to high capital requirements and stringent regulations. Competitive rivalry: The global Active Pharmaceutical Ingredients market is highly competitive due to presence of major international players. Key players analysis: Key players operating in the Active Pharmaceutical Ingredients market are Endo International plc, Teva Pharmaceutical Industries Ltd, Viatris Inc. The global Active Pharmaceutical Ingredients market is highly competitive due fragmentation of industry and presence of numerous international and regional vendors.

Global Active Pharmaceutical Ingredients (APIs) Market will be US$ 261.3 Billion by 2027

renubresearch 2023-01-24

According to Renub Research's latest report, "Global Active Pharmaceutical Ingredients (API) Market, Size, forecast 2023-2027, Industry Trends, Share, Growth, Company Analysis," the Global API (Active Pharmaceutical Ingredients) Market will reach US$ 261. Competitive Landscape:The key competitors who are dealing in active pharmaceutical ingredients (API) are; Sanofi SA, F. Synthetic - Global Active Pharmaceutical Ingredients Market breakup into two viewpoints (Biotech and Synthetic). Manufacturer Type - By manufacturer type, Global Active Pharmaceutical Ingredients Market break up into two viewpoints (Captive and Merchant). Application - Global Active Pharmaceutical Ingredients Market breaks up into six viewpoints (cardiology, oncology, CNS and neurology, orthopedic, endocrinology, and others).

Active Pharmaceutical Ingredients: The Core of Any Medicine

Omkar Patel 2024-02-20

At the heart of any medicine lies the active pharmaceutical ingredient (API) that is responsible for the intended medical benefit. An active pharmaceutical ingredient, commonly abbreviated as API, refers to the biologically active component of any pharmaceutical drug product. Rigorous quality control checks are performed during all stages of API development and manufacturing. Key Global API Producers and Suppliers The API industry has grown immensely with several major producers worldwide. - North China Pharmaceutical Group (China): One of China's biggest producers of bulk APIs catering to both domestic and foreign pharmaceutical needs.

Active Pharmaceutical Ingredients (API) Market worth $248.3 billion by 2025

Makarand Vaidya 2022-04-01

Expected Growth in Revenue Generation:The global active pharmaceutical ingredients market is projected to reach USD 248. id=263In 2019, the innovative APIs segment accounted for the largest share of the active pharmaceutical ingredients marketBased on type, the active pharmaceutical ingredients market is segmented into innovative and generic APIs. The innovative APIs segment accounted for the largest share of the global active pharmaceutical ingredients market in 2019. North America was the largest regional market for active pharmaceutical ingredients market in 2019The global active pharmaceutical ingredients market is segmented into North America, Europe, Asia, Latin America, and Rest of the World. In 2019, North America accounted for the largest share of the active pharmaceutical ingredients market, followed by Europe and the Asia.

India Active Pharmaceutical Ingredients Market Growth is Accelerated by Increasing Generic Drugs Manufacturing

Sumedha 2024-01-15

The active pharmaceutical ingredients (API) are the component of any drug that produces its effects. The rising prevalence of chronic diseases and growing geriatric population propel the demand for affordable drugs, boosting the active pharmaceutical ingredients market in India. This opportunity can propel the growth of the active pharmaceutical ingredients market in India over the forecast period. Porter's AnalysisThreat of new entrants: The threat of new entrants in the India active pharmaceutical ingredients market is moderate. Key TakeawaysThe India Active Pharmaceutical Ingredients Market Size is expected to witness high growth over the forecast period of 2023-2030 supported by a growing domestic pharmaceutical industry and rising exports.

WHO TO FOLLOW

MORE FROM AUTHOR

Global Wearable Artificial Kidney Market is Poised to Grow at a Robust Pace Due to Rising Incidences of Kidney Failure

Poonam 21h

Fortifying Safety: The Evolution of Blast Resistant and Bulletproof Buildings

Poonam 22h

Unlocking Garden Success: The Power Of Premium Potting Soils

Poonam 22h

The Importance Of Building Code Compliance: Safeguarding Safety And Quality

Poonam 23h

Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.

Press enter to search

Active Pharmaceutical Ingredients Market 2023 - By Size, Segmentation, Application, Outlook And Opportunities Analysis By 2032

sai tbrc 2023-09-19

The Active Pharmaceutical Ingredients Global Market Report 2023, provides comprehensive information on the active pharmaceutical ingredients market across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The market size of the active pharmaceutical ingredients market is expected to grow to $275. id=8539&type=smp The active pharmaceutical ingredients market is segmented:1) By Type: Innovative APIs (Active Pharmaceutical Ingredient), Generic APIs (Active Pharmaceutical Ingredient)2) By Type Of Manufacturer: Captive Manufacturers, Merchant Manufacturers3) By Type Of Synthesis: Synthetic APIs (Active Pharmaceutical Ingredient), Biotech APIs (Active Pharmaceutical Ingredient)4) By Type Of Drug: Prescription Drugs, Over-The-Counter Drugs5) By Therapeutic Application: Communicable Diseases, Oncology, Diabetes, Cardiovascular Disease, Pain Management, Respiratory Diseases, Other Therapeutic Applications North America was the largest region in the active pharmaceutical ingredients market in 2022. Africa Active Pharmaceutical Ingredients Market27. Key Mergers And Acquisitions In The Active Pharmaceutical Ingredients Market29.

The Pigmentation Disorders Treatment Market: Advancements and Outlook

harries jackson 2023-08-11

The global pigmentation disorders treatment market has witnessed significant growth in recent years, driven by advancements in medical technology, increasing awareness about skin health, and a growing demand for effective solutions to various pigmentation disorders. One of the key drivers of the pigmentation disorders treatment market is the rise in research and development activities. Advancements in genetic research have allowed for a deeper understanding of the underlying genetic factors that contribute to The global Pigmentation Disorders Treatment Market was valued at US$ 6. Geographically, the Asia-Pacific region has emerged as a prominent market for pigmentation disorders treatment. The pigmentation disorders treatment market continues to evolve with technological advancements and a growing understanding of the complex factors contributing to these disorders.

Active Pharmaceutical Ingredients (API) Market Volume Forecast and Value Chain Analysis 2021 to 2026

Mark Smith 2022-01-24

According to the latest report by IMARC Group, titled "Active Pharmaceutical Ingredients (API) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026," the global active pharmaceutical ingredients (API) market report reached a value of US$ 200. An active pharmaceutical ingredient (API) is an active component of a drug that plays a vital part in the formulation of pharmaceutical drugs. com/active-pharmaceutical-ingredients-market/requestsampleGlobal Active Pharmaceutical Ingredients (API) Market Trends:The global market is majorly driven by significant growth in the pharmaceutical industry. Furthermore, the rising geriatric population, which is highly susceptible to developing fatal medical conditions, is providing a thrust to market growth. Abbvie IncActive Pharmaceutical Ingredients (API) Market Segmentation:Our report has categorized the market based on region, drug type, manufacturer, synthesis and therapeutic application.

Active Pharmaceutical Ingredients Market Industry Size, Share, Trends - Forecast Analysis 2021-2025

Melisa John 2021-10-07

Active Pharmaceutical Ingredients Market to grow by $ 64.53billion|Key Drivers and Trends|TechnavioAccording to Technavio, the active pharmaceutical ingredients market size is expected to value at $ 64.53 billion during 2021-2025.

The market sizing analysis in the report reveals that the market growth will progressing at a CAGR of over 6.10%.

The report offers exclusive detailed COVID-19 impact study, which majorly highlights vendor performance and new business opportunities during and post pandemic period.View our exclusive report on the CMOS image sensors market covering market trends, vendor analysis, and growth opportunities to improve your business - Download Free Sample Report.Active Pharmaceutical Ingredients Market Trends & DriversThe active pharmaceutical ingredients market research report has a detailed analysis on the key drivers, trends, and challenges, which will help vendors in making important business decisions and modifications to cater to the changing consumer demand.

While it is essential to capitalize on key drivers such as evolving api manufacturing scenario in developing countries, it is also crucial to understand the challenges that will impede sales during the forecast period.

Identifying and addressing market growth challenges will create additional opportunities for the existing and new market players.

Know more about COVID-19 Crisis and Recovery Analysis?

Active Pharmaceutical Ingredients Market Revenue Analysis, Company Revenue Share, Global Forecast Till 2032

David 2023-09-06

Overall, the global active pharmaceutical ingredients market has been segmented in terms of therapeutic category, synthesis, contract outsourcing, application, drug, and region. In the regional context, the North America active pharmaceutical ingredients market is set to grow significantly through 2032, owing to the availability of a range of pharmaceutical companies in the region. com/toc/detail/active-pharmaceutical-ingredients-marketAbout Global Market Insights:Global Market Insights, Inc. , is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Toll Free: 1-888-689-0688USA: +1-302-846-7766Europe: +44-742-759-8484APAC: +65-3129-7718Email:sales@gminsights.

Growth Prospects of the India Active Pharmaceutical Ingredients Market

Pooja salve 2023-07-07

The India Active Pharmaceutical Ingredients (API) market is experiencing promising growth prospects driven by various factors. With a strong presence in the global pharmaceutical industry, India has become a major API supplier worldwide. The rising burden of chronic diseases, a growing geriatric population, and the expansion of the generic drug market are further driving the India Active Pharmaceutical Ingredients Market demand. The India API market holds immense growth potential due to favorable market dynamics, government support, and the country's strong manufacturing capabilities. The India Active Pharmaceutical Ingredients (API) market has emerged as a thriving sector within the pharmaceutical industry.

High Potency Active Pharmaceutical Ingredients (HPAPIs) Market 2022 | Industry Demand, Fastest Growth, Opportunities Analysis and Forecast To 2028

Beena Daas 2022-02-16

Get more information on "Global High Potency Active Pharmaceutical Ingredients (HPAPIs) Market Research Report" by requesting FREE Sample Copy at https://www. com/contact/high-potency-active-pharmaceutical-ingredients-hpapis-market/download-sampleMarket DynamicsThe global high potency active pharmaceutical ingredients (HPAPIs) market is projected to grow at an impressive rate during the forecast period. Browse Global High Potency Active Pharmaceutical Ingredients (HPAPIs) Market Research Report with detailed TOC at https://www. com/report/high-potency-active-pharmaceutical-ingredients-hpapis-marketMarket SegmentationThe entire high potency active pharmaceutical ingredients (HPAPIs) market has been sub-categorized into product, manufacturer, drug type and application. Purchase Complete Global High Potency Active Pharmaceutical Ingredients (HPAPIs) Market Research Report at https://www.

Active Pharmaceutical Ingredients (APIs) Market Size to Hit $215,125.4 Million by 2023 at 4.96% CAGR

Bhagyashri Bhole 2020-02-10

Global Active Pharmaceutical Ingredients Market Research Report: Information by Manufacturing Process (Captive Manufacturing and Contract Manufacturing), Type of Synthesis (Synthetic and Biotech), by API Formulation (Generic API and Branded/Innovative API), Application (Cardiovascular Disease, Oncology, Neurological Disorders, Orthopedic Disorders, Respiratory, Gastrointestinal Disorders, Urology and others), Molecules (Large Molecule and Small Molecule) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2023The Global Active Pharmaceutical Ingredients Market Report shows market is expected to exhibit a strong 4.96% CAGR over the forecast period from 2018 to 2023, according to the latest research report from Market Research Future (MRFR).

According to MRFR, the global active pharmaceutical ingredients market is expected to reach a valuation of USD 215,125.4 million by 2023.Active pharmaceutical ingredients comprise the pharmaceutically active agent in any medicine, i.e.

The growing prevalence of chronic diseases such as cardiovascular diseases (CVDs) and cancer is likely to be the major driver for the global active pharmaceutical ingredients market over the forecast period.

The growing healthcare industry and biotech sector are also likely to be major drivers for the active pharmaceutical ingredients market, as drug development has emerged as a major target for players operating in these fields.

Finding effective cures for various cancers has also emerged as a major objective for players in the active pharmaceutical ingredients market over the last few years.

Generics are copies of branded drugs that can be sold at much lower prices due to the absence of a copyright.

India Active Pharmaceutical Ingredients Market Forecast and Oppotunity 2027

Nirbhay Kulshrestha 2023-03-21

Increasing incidence of chronic diseases is expected to drive the growth of India Active Pharmaceutical Ingredients market during the forecast period. Browse 21 Figures spread through 70 Pages and an in-depth TOC on “ India Active Pharmaceutical Ingredients Market”https://www. htmlThe India active pharmaceutical ingredients market is segmented based on method of synthesis, source, therapeutic application, drug type, company, and region. , Solara Active Pharma Sciences, GlaxoSmithKline Pharmaceuticals Ltd, and others are some of the major players operating in the India active pharmaceutical ingredients market. This is further expected to create lucrative opportunities for the market growth of India Active Pharmaceutical Ingredients market over the next five years.

Rising consumption of The Active Pharmaceutical Ingredients the Covid-19 Pandemic Have Strengthen the Market Growth

Ankit Gupta 2021-09-01

The Global Active Pharmaceutical Ingredients Market is accounted approximate USD 180.5 billion in 2020 and it is expected to reach approximate USD 308.3 billion by 2030 with a CAGR of 5.5% during forecast period.

While pharmaceutical innovation is saving the globe, biopharma and medtech firms now have a chance to keep up the trend.Market Dynamics and Factors:The life sciences business has seen exponential development in terms of breadth and capabilities across the value chain.

The need for significant collaboration between life sciences and healthcare firms, not just on goods but also on solutions, to assist solve the demand-supply mismatch is one of the sector's main issues.

The pandemic will likely increase demand for Active Pharmaceutical Ingredients in resource management, such as vaccinations, medications, and other critical medical supplies.Furthermore, throughout the projection period, the growing elderly population, rising noncommunicable illness prevalence and rising desire for enhanced patient experience are expected to drive revenue.

Governments in both developed and emerging markets have made deliberate decisions to confront producers and demand more access to lower-cost medications.

By mode of synthesis, the market can be segmented into synthetic API and biotech API.

Exploring the Role of Activated Pharmaceutical Ingredients in Drug Formulation

nicovaper 2023-07-21

IntroductionIn the fast-paced world of pharmaceutical drug formulation, activated pharmaceutical ingredients (APIs) play a pivotal role. Definition and Characteristics of Activated Pharmaceutical Ingredients (APIs)APIs are the biologically active substances within a drug that produce the desired pharmacological effect. Role of APIs in Drug Delivery SystemsAPIs contribute to the development of controlled release and targeted drug delivery systems, allowing for optimized drug release profiles and site-specific targeting. Nanotechnology-based drug delivery systems have shown promise in enhancing API delivery to specific tissues or cells. ConclusionActivated pharmaceutical ingredients are the backbone of drug formulation, enabling the development of effective and safe therapeutic solutions.

Active Pharmaceutical Ingredients Global Market 2024 - By Demand, Growth Factors, Trends, Key Drivers Forecast To 2033

varun@tbrc 2024-01-12

Learn More On The Active Pharmaceutical Ingredients Market:https://www. The active pharmaceutical ingredients market size is expected to see strong growth in the next few years. The increasing incidence of chronic diseases is expected to propel the growth of the active pharmaceutical ingredients market going forward. The active pharmaceutical ingredients market report table of contents includes:1. Executive SummaryActive Pharmaceutical Ingredients Market CharacteristicsActive Pharmaceutical Ingredients Market Trends And StrategiesActive Pharmaceutical Ingredients Market - Macro Economic ScenarioGlobal Active Pharmaceutical Ingredients Market Size and Growth.

Expanding Possibilities: CD Formulation Unveils Comprehensive Selection of 90+ Active Pharmaceutical Ingredients

CD Formulation 2023-08-23

The company recently unveiled its latest collection of over 90 active pharmaceutical ingredients (APIs) to the scientific community. These APIs will serve as essential components in the formulation of various drugs. Some of these APIs include: Ascorbic Acid (Vitamin C) (CAS 50-81-7), FUSIDIC ACID (CAS 6990-06-3), SODIUM FUSIDATE (CAS 751-94-0), AMIKACIN SULFATE (CAS 39831-55-5), Tinidazole (CAS 19387-91-8), Linezolid (CAS 165800-03-3), Levofloxacin acid ester (CAS 106939-34-8), Metronidazole (CAS 443-48-1), and Norfloxacin (CAS 70458-96-7). The company offers a range of cardiovascular APIs that are essential for managing heart disease, lowering cholesterol and regulating blood pressure. To name just a few: Rivaroxaban (CAS 366789-02-8), Edaravone (CAS 89-25-8), Heparin Sodium (CAS 9041-08-1), Lomerizine Dihydrochloride (CAS 101477-54-7) and Enoxaparin Sodium (CAS 679809-58-6).

Active Pharmaceutical Ingredients Market – The New Ways to Win in Emerging Markets Forecast to 2020-2027

Ashish Mandar 2020-11-18

The report covers an overview of the industry along with a detailed explanation that provides a lot of insight.

The report also analyzes the production as well as management technology in various end-user industries.

An in-depth study in some new and prominent industry trends, analysis of the competition and regional analysis that is very detailed have been included in the report of the Active Pharmaceutical Ingredients market for the review period of 2020 – 2027.There are many different factors that have caused the quick expansion of the Active Pharmaceutical Ingredients market.

In addition to the above, government initiatives, as well as the competitive landscape that exists in the Active Pharmaceutical Ingredients market through the forecast period, has been analyzed.Ask for report free sample with complete TOC and list of tables/figures @ https://www.datalibraryresearch.com/sample-request/active-pharmaceutical-ingredients-market-2103Global Active Pharmaceutical Ingredients Market Key Companies:Teva Pharmaceuticals Ltd.SandozLonza Group-AGDSMReddy’s Lab Ltd.Boehringer Ingelheim GmbHThe base year of the study is 2020 and the forecast period stretches all the way till 2027.

This has led to the creation of a strong understanding of the market for the upcoming years.

In addition to the regional segmentation, the report carries out segmentation in order to obtain detailed as well as insightful insights into the market.